{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:24:26Z","timestamp":1791919466927,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001563","name":"Otago Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001563","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bbrc.2014.08.068","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T06:51:22Z","timestamp":1408603882000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Molecular mechanism of an adverse drug\u2013drug interaction of allopurinol and furosemide in gout treatment"],"prefix":"10.1016","volume":"452","author":[{"given":"Claudia","family":"Knake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.08.068_b0005","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/rheumatology\/kes091","article-title":"Furosemide increases plasma oxypurinol without lowering serum urate \u2013 a complex drug interaction: implications for clinical practice","volume":"51","author":"Stamp","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbrc.2014.08.068_b0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-2952(88)90739-3","article-title":"Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical","volume":"37","author":"Spector","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.08.068_b0015","first-page":"1120","article-title":"The treatment of gout and disorders of uric acid metabolism with allopurinol","volume":"95","author":"Ogryzlo","year":"1966","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.bbrc.2014.08.068_b0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","article-title":"Clinical practice. Gout","volume":"364","author":"Neogi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2014.08.068_b0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/meta.2001.19489","article-title":"Effect of furosemide on renal excretion of oxypurinol and purine bases","volume":"50","author":"Yamamoto","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2014.08.068_b0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/B:CARD.0000015855.02485.e3","article-title":"Cardiovascular drugs and serum uric acid","volume":"17","author":"Reyes","year":"2003","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bbrc.2014.08.068_b0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/annrheumdis-2011-201186","article-title":"A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study","volume":"72","author":"McAdams-DeMarco","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrc.2014.08.068_b0040","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1124\/jpet.103.059139","article-title":"Interactions of human organic anion transporters with diuretics","volume":"308","author":"Hasannejad","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2014.08.068_b0045","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1681\/ASN.2007010106","article-title":"Torasemide transport by organic anion transporters contributes to hyperuricemia","volume":"18","author":"Hagos","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2014.08.068_b0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1681\/ASN.2006040415","article-title":"Human renal organic anion transporter 4 operates as an asymmetric urate transporter","volume":"18","author":"Hagos","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2014.08.068_b0055","doi-asserted-by":"crossref","first-page":"35123","DOI":"10.1074\/jbc.M110.121301","article-title":"Human sodium phosphate transporter 4 (hNPT4\/SLC17A3) as a common renal secretory pathway for drugs and urate","volume":"285","author":"Jutabha","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.08.068_b0060","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/bjp.2008.343","article-title":"Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4","volume":"155","author":"El-Sheikh","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.08.068_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/ajprenal.00680.2010","article-title":"Avian renal proximal tubule urate secretion is inhibited by cellular stress-induced AMP-activated protein kinase","volume":"300","author":"Bataille","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbrc.2014.08.068_b0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.08.068_b0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.2012.04207.x","article-title":"The pharmacokinetics of oxypurinol in people with gout","volume":"74","author":"Stocker","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.08.068_b0080","doi-asserted-by":"crossref","first-page":"26834","DOI":"10.1074\/jbc.C800156200","article-title":"Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans","volume":"283","author":"Anzai","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.08.068_b0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/AAC.44.3.574-577.2000","article-title":"Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1","volume":"44","author":"Uchino","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2014.08.068_b0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3899\/jrheum.121301","article-title":"Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population","volume":"40","author":"Pui","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbrc.2014.08.068_b0095","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1074\/jbc.275.8.5918","article-title":"Repressed expression of the human xanthine oxidoreductase gene. E-box and TATA-like elements restrict ground state transcriptional activity","volume":"275","author":"Xu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.08.068_b0100","doi-asserted-by":"crossref","first-page":"F1327","DOI":"10.1152\/ajprenal.00680.2010","article-title":"Avian renal proximal tubule urate secretion is inhibited by cellular stress-induced AMP-activated protein kinase","volume":"300","author":"Bataille","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbrc.2014.08.068_b0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2014.08.068_b0110","first-page":"14","article-title":"Emerging role of microRNAs in drug response","volume":"12","author":"Zhang","year":"2010","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.bbrc.2014.08.068_b0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molmed.2011.04.003","article-title":"MicroRNA pharmacogenomics: post-transcriptional regulation of drug response","volume":"17","author":"Rukov","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2014.08.068_b0120","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1101\/gr.139758.112","article-title":"Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation","volume":"23","author":"Hausser","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2014.08.068_b0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.21.83","article-title":"Drug-metabolizing ability of molybdenum hydroxylases","volume":"21","author":"Kitamura","year":"2006","journal-title":"Drug Metab. Pharmacokinet."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14014910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14014910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:29:34Z","timestamp":1762093774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14014910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0006291X14014910"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.068","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism of an adverse drug\u2013drug interaction of allopurinol and furosemide in gout treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}